EE200200454A - Noretisterooni sisaldav meeste kontratseptiivne preparaat - Google Patents

Noretisterooni sisaldav meeste kontratseptiivne preparaat

Info

Publication number
EE200200454A
EE200200454A EEP200200454A EEP200200454A EE200200454A EE 200200454 A EE200200454 A EE 200200454A EE P200200454 A EEP200200454 A EE P200200454A EE P200200454 A EEP200200454 A EE P200200454A EE 200200454 A EE200200454 A EE 200200454A
Authority
EE
Estonia
Prior art keywords
norethisterone
testosterone
male contraceptive
males
progestin
Prior art date
Application number
EEP200200454A
Other languages
English (en)
Estonian (et)
Inventor
Nieschlag Eberhard
Kamischke Axel
Oettel Michael
Ruebig Alexander
Schillinger Ekkerhard
Habenicht Ursula-Friederike
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200454A publication Critical patent/EE200200454A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EEP200200454A 2000-02-15 2001-02-15 Noretisterooni sisaldav meeste kontratseptiivne preparaat EE200200454A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
EP00200493 2000-02-15
PCT/IB2001/000188 WO2001060376A1 (fr) 2000-02-15 2001-02-15 Preparation contraceptive masculine comprenant de la norethistereone

Publications (1)

Publication Number Publication Date
EE200200454A true EE200200454A (et) 2003-12-15

Family

ID=26071832

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200454A EE200200454A (et) 2000-02-15 2001-02-15 Noretisterooni sisaldav meeste kontratseptiivne preparaat

Country Status (26)

Country Link
EP (2) EP1267885B8 (fr)
JP (1) JP2003522795A (fr)
KR (1) KR20020086905A (fr)
CN (1) CN1423560A (fr)
AT (2) ATE355844T1 (fr)
AU (1) AU2001230447A1 (fr)
BG (1) BG107066A (fr)
BR (1) BR0108411A (fr)
CA (1) CA2398063A1 (fr)
CY (1) CY1106639T1 (fr)
CZ (1) CZ20022691A3 (fr)
DE (2) DE60142647D1 (fr)
DK (1) DK1267885T3 (fr)
EE (1) EE200200454A (fr)
ES (1) ES2282230T3 (fr)
HK (1) HK1049442B (fr)
HU (1) HUP0300128A3 (fr)
IL (1) IL151219A0 (fr)
MX (1) MXPA02007675A (fr)
NO (1) NO20023607L (fr)
PL (1) PL357185A1 (fr)
PT (1) PT1267885E (fr)
RU (1) RU2002124602A (fr)
SI (1) SI1267885T1 (fr)
SK (1) SK11602002A3 (fr)
WO (1) WO2001060376A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
CA2492079C (fr) 2002-07-24 2012-01-10 Schering Aktiengesellschaft Procedes microbiologiques permettant de produire des 11 alpha-hydroxysteroides 7 alpha-substitues
WO2004011008A1 (fr) * 2002-07-25 2004-02-05 Schering Aktiengesellschaft COMPOSITION CONTENANT UN 11β-HALOGENOSTEROIDE ANDROGENE ET UN GESTAGENE, ET CONTRACEPTIF MASCULIN A BASE DE CETTE COMPOSITION
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂
IL277372B2 (en) 2018-03-23 2023-09-01 Laboratoires Major Non-hormonal preparations including (r)-silodosin and male contraceptive methods, including once-daily administration of (r)-silodosin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Also Published As

Publication number Publication date
EP1666044B1 (fr) 2010-07-21
DE60142647D1 (de) 2010-09-02
CA2398063A1 (fr) 2001-08-23
HUP0300128A2 (en) 2003-05-28
IL151219A0 (en) 2003-04-10
ES2282230T3 (es) 2007-10-16
JP2003522795A (ja) 2003-07-29
KR20020086905A (ko) 2002-11-20
DE60127103D1 (de) 2007-04-19
EP1267885B8 (fr) 2007-06-20
HK1049442B (zh) 2007-06-15
HUP0300128A3 (en) 2004-03-29
ATE355844T1 (de) 2007-03-15
EP1267885A1 (fr) 2003-01-02
RU2002124602A (ru) 2004-03-10
PT1267885E (pt) 2007-05-31
CZ20022691A3 (cs) 2003-01-15
DE60127103T2 (de) 2007-11-22
CN1423560A (zh) 2003-06-11
SI1267885T1 (sl) 2007-08-31
BR0108411A (pt) 2003-03-11
WO2001060376A1 (fr) 2001-08-23
NO20023607D0 (no) 2002-07-30
NO20023607L (no) 2002-10-15
DK1267885T3 (da) 2007-07-09
BG107066A (en) 2003-05-30
EP1267885B1 (fr) 2007-03-07
SK11602002A3 (sk) 2003-03-04
HK1049442A1 (en) 2003-05-16
CY1106639T1 (el) 2012-01-25
ATE474580T1 (de) 2010-08-15
EP1666044A1 (fr) 2006-06-07
MXPA02007675A (es) 2004-02-26
AU2001230447A1 (en) 2001-08-27
PL357185A1 (en) 2004-07-26

Similar Documents

Publication Publication Date Title
CY1106639T1 (el) Τυποποιηση αντισυλληπτικου για ανδρες που περιλαμβανει νορεθιστερονη
NO20032805D0 (no) Preparater av östrogensyklodekstrinkomplekser
RU99118582A (ru) Композиция для чрескожного введения стероидных лекарственных средств
ES2123547T3 (es) Formulaciones, metodos y dispositivos contraceptivos transdermicos.
GEP20053586B (en) Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same
FI925652A (fi) Foerfarande och sammansaettningar foer foerhindrande av befruktning och behandling av benigna gynekologiska stoerningar
KR970010784A (ko) 11-(치환된 페닐)-에스트라-4,9-디엔 유도체
DE59510887D1 (de) Feste arzneiformen, enthaltend clathrate vom steroidalen sexualhormon ethinylestradiol
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
WO2001003687A3 (fr) Procede et compositions d'inhibition de la biosynthese ou de la bioactivite d'hormones sexuelles steroidiennes endogenes chez des sujets humains
DE59805902D1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
AR027526A1 (es) Formulacion anticonceptiva masculina que comprende noretisterona
EP1513588B1 (fr) Utilisation de nouveaux esters d'etonogestrel
JP2003522795A5 (fr)
MXPA03000845A (es) Estrogenos substituidos por 16alfa-metilo o etilo.
GB1060632A (en) Steroid compositions
PE20020709A1 (es) Composiciones de complejos de estrogeno-ciclodextrina
CU22840A1 (es) Derivados esteroidales de la serie del androstano sustituídos en el anillo c que presentan marcada actividad anabólica e insignificante actividad androgénica
AR018349A1 (es) Composicion farmaceutica que comprende estrogenos y antiestrogenos y su uso para la manufactura de un medicamento